Cost-effectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriers
about
MRI screening for breast cancer in women at high risk; is the Australian breast MRI screening access program addressing the needs of women at high risk of breast cancer?Expanding the indications for MRI in the diagnosis and treatment of breast cancer: what is best practice?Breast cancer screening: an evidence-based updateAn international survey of surveillance schemes for unaffected BRCA1 and BRCA2 mutation carriers.Cost-effectiveness of alternative strategies for integrating MRI into breast cancer screening for women at high risk.Imaging-based screening: understanding the controversies.Comparison of false positive rates for screening breast magnetic resonance imaging (MRI) in high risk women performed on stacked versus alternating schedules.MARIA M4: clinical evaluation of a prototype ultrawideband radar scanner for breast cancer detectionContralateral Prophylactic Mastectomy Consensus Statement from the American Society of Breast Surgeons: Additional Considerations and a Framework for Shared Decision Making.Breast Cancer Screening for High-Risk Patients of Different Ages and Risk - Which Modality Is Most Effective?The 2013 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: MRI in breast cancer: where are we now?Outcomes of genetic evaluation for hereditary cancer syndromes in unaffected individuals.The role of dynamic contrast-enhanced screening breast MRI in populations at increased risk for breast cancer.Contralateral Prophylactic Mastectomy with Immediate Breast Reconstruction Increases Healthcare Utilization and Cost.Screening MRI in Women With a Personal History of Breast Cancer.MRI breast screening in high-risk women: cancer detection and survival analysis.Simulation modeling for stratified breast cancer screening - a systematic review of cost and quality of life assumptions.Cost-effectiveness and comparative effectiveness of cancer risk management strategies in BRCA1/2 mutation carriers: a systematic review.
P2860
Q26785571-5F1A3FB1-0178-4004-8062-4423867CE617Q26801072-9BE7F445-0DC4-429A-8C86-91A08A189253Q28081267-6D9EB8FB-28B3-4ACE-9E78-775B81AA6F87Q33901361-7BE09C2E-4035-486D-AEFB-917A47E8DF3AQ34354614-950BC597-83FD-4191-81A4-37670D880A42Q34452684-E4F5D5FF-F1B6-4E3F-9060-D881408AA802Q35122658-3FB9D860-9C2A-4AF7-9D29-75D54730A083Q37110737-E2953609-457F-4B70-A5C9-06519098AFBCQ37208201-14B32E1A-CDD2-4850-AB43-3AE9475F55C1Q37608651-8B7C9230-C53D-49A7-9B54-7BA611F283A8Q38154495-A0D0E092-6461-4512-89C3-586E7ED8D945Q38253213-1D8162B9-E1ED-444F-9265-21CA397D9C34Q38284365-910DCB8B-B9DD-40C6-B76C-52A8E1EC6D03Q38647477-5E12E23E-5926-4E53-BF9C-1936D6AC38BBQ40130076-AC6BA3ED-0C6C-4BCD-9862-DB320D6B6F8FQ45243016-EB3B1BBF-8E3A-4078-9386-989F31FD0717Q47094586-75D5A080-281A-4FA4-A82E-20310661E712Q50091589-962D5320-9913-4E3E-9D58-3642E47B1BD5
P2860
Cost-effectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriers
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Cost-effectiveness of alternat ...... d BRCA2 gene mutation carriers
@ast
Cost-effectiveness of alternat ...... d BRCA2 gene mutation carriers
@en
type
label
Cost-effectiveness of alternat ...... d BRCA2 gene mutation carriers
@ast
Cost-effectiveness of alternat ...... d BRCA2 gene mutation carriers
@en
prefLabel
Cost-effectiveness of alternat ...... d BRCA2 gene mutation carriers
@ast
Cost-effectiveness of alternat ...... d BRCA2 gene mutation carriers
@en
P2093
P2860
P356
P1433
P1476
Cost-effectiveness of alternat ...... d BRCA2 gene mutation carriers
@en
P2093
Chung Y Kong
Elkan F Halpern
G Scott Gazelle
Janie M Lee
Jessica E Cott Chubiz
Kathryn P Lowry
Michael E Gilmore
Paula D Ryan
P2860
P304
P356
10.1002/CNCR.27864
P407
P577
2012-11-26T00:00:00Z